Press Releases

Home > Press Releases

Press Releases (Page 169)

medac unveils new Global Corporate Brand

WEDEL, Germany, March 11, 2024 (GLOBE NEWSWIRE) -- The pharmaceutical company medac, founded in Germany in 1970, has evolved into an internationally renowned corporate group with two contract development and manufacturing organizations in Europe and a distribution to 91 countries. The focus of medac’s work is on improving established pharmaceutical products as well as developing new therapeutics in four key areas rheumatology,... ❯❯❯

DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce that it has been accepted into the Hamilton Ecosystem to Accelerate and Leverage Trials of Health Innovation (“HEALTHI”) program to accelerate the clinical research and commercialization efforts in Canada for the Company’s CERVAI™... ❯❯❯

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings... ❯❯❯

Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update

Leadership Changes Led by Appointment of Co-Founder Thomas Jensen as Interim CEO and Jeremy Graff, Ph.D., former Eli Lilly Executive, as Executive AdvisorReduced Net Loss from Operations by 50% and Reduced Net Loss by 26%Announced Data in December 2023 from Advanced Ovarian Cancer Phase 2 Stenoparib Study Showing Significant Clinical Benefit Boston (March 8, 2024) — Allarity Therapeutics, Inc. (“Company”) (NASDAQ: ALLR), a clinical-sta... ❯❯❯

RadNet Announces Pricing of Public Offering of Common Stock

LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $44.00 per share. The gross proceeds to RadNet from the offering, before deducting the underwriting discounts and... ❯❯❯

Extendicare Announces 2023 Fourth Quarter and Year End Results

MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023. Results are presented in Canadian dollars unless otherwise noted. Fourth Quarter 2023 Highlights Adjusted EBITDA(1) increased $19.5 million in Q4 to $28.7 million, driven by home health care volume growth and rate increases; growth in... ❯❯❯

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31, 2023, before the market opens on Monday, March 18, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30... ❯❯❯

RadNet Announces Proposed $200 Million Underwritten Public Offering of Common Stock

LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today that it intends to offer and sell, subject to market and other conditions, an underwritten public offering of $200,000,000 of shares of common stock. In addition, RadNet intends to grant the underwriters a 30-day option to purchase... ❯❯❯

Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments

Jodi Bryant joins as President, Healthcare, Matt Moran as Chief Strategy Officer, and Cody Fair elevated to Chief Commercial Officer NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better and healthier lives, is pleased to announce three key healthcare leadership appointments: Jodi Bryant as President, Healthcare, Matt... ❯❯❯

USOSM Chief Operations and Chief Human Resources Officers to Speak at Women in DSO’s Empower and Grow Conference

IRVING, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey and USOSM Chief Human Resources Officer Annette Igl will be panel speakers in the upcoming Empower and Grow conference, presented by Women in DSO, a nonprofit dedicated to the advancement of women leaders in the dental industry. The conference will be held March 6-8 at Conrad Las Vegas Resorts World, located at... ❯❯❯